SGLT2 Inhibition Across a Range of Left Ventricular Hypertro

Muthiah Vaduganathan, MD, MPH, discusses a presentation from ACC.24 assessing the effects of dapagliflozin across a range of left ventricular hypertrophy from DELIVER.

Related Keywords

Campbellp Dapagliflozin , Muthiah Vaduganathan , Boehringer Ingelheim Pharmaceuticals , Astrazeneca , Bayer Ag , Amgen , American College Of Cardiology , American College , Annual Scientific Sessions , Cardiometabolic Implementation Science , Hazard Ratio , Confidence Interval , Annual Scientific ,